JIANGXI FUSHINE PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.96 CNY | -2.21% |
|
-2.69% | +27.78% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Jiangxi Fushine Pharmaceutical Co., Ltd. is principally engaged in research and development, manufacturing and sales of bulk drugs, pharmaceutical intermediates and related products. The Company's main products include sulbactam series enzyme inhibitor bulk drugs, pharmaceutical intermediates and related products, tazobactam series enzyme inhibitor bulk drugs, pharmaceutical intermediates and related products, as well as intermediates of carbapenems bulk drugs. The Company distributes its products within domestic markets and to overseas markets, including European Union (EU) and other countries and regions in Asia.
Sector
Pharmaceuticals
Calendar
20/05/2024
- Annual General Meeting
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +27.78% | 892M | |
| +31.37% | 595B | |
| -2.60% | 367B | |
| +20.83% | 334B | |
| +5.69% | 289B | |
| +14.83% | 239B | |
| +9.93% | 211B | |
| -6.95% | 203B | |
| +10.77% | 171B | |
| +0.10% | 163B |
- Stock Market
- Equities
- 300497 Stock
- News Jiangxi Fushine Pharmaceutical Co., Ltd.
- Fushine Pharmaceutical's Unit Gets Nod to Market Antidepressant
